|
Trial no.:
|
PACTR202203637285531 |
Date of Registration:
|
10/03/2022 |
|
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
| TRIAL DESCRIPTION |
|
Public title
|
Short-term outcomes of double omentopexy in OAGB: A Controlled Clinical Trial |
| Official scientific title |
Short-term outcomes of double omentopexy in one anastomosis gastric bypass surgery: A Controlled Clinical Trial |
|
Brief summary describing the background
and objectives of the trial
|
Omentopexy is a novel technique performed during the laparoscopic sleeve gastrectomy. In general, in the method, the remnant stomach is fixed to the gastrosplenic and gastrocolic ligaments.
Despite the obvious advantages of one anastomosis gastric bypass surgery, it also has its own complications. Leaks still represent the most common complication of this intervention (0.1%
to 1.9%), once a leak is identified, aggressive management strategies must be implemented to avoid further complications. Bleeding is the second most common complication and presents usually in the early postoperative setting. It commonly originates from the staple lining along with the gastric pouch, gastric remnant, or gastro-jejunal (GJ) anastomosis, with a rate of less than 3%.
Other complications may include small bowel obstruction and dumping syndrome, stomal stenosis, marginal ulcer along mal-absorptive complications. The purpose of this study is to assess the efficacy of implementing a novel technique of reinforcement of gastric pouch and remnant stomach staple line with omentopexy in patients undergoing one-anastomosis gastric bypass surgery and to evaluate its impact in reducing post-operative complications.
|
| Type of trial |
CCT |
| Acronym (If the trial has an acronym then please provide) |
|
| Disease(s) or condition(s) being studied |
Nutritional, Metabolic, Endocrine |
| Sub-Disease(s) or condition(s) being studied |
|
| Purpose of the trial |
Treatment: Surgery |
| Anticipated trial start date |
15/03/2022 |
| Actual trial start date |
15/05/2022 |
| Anticipated date of last follow up |
15/09/2022 |
| Actual Last follow-up date |
|
| Anticipated target sample size (number of participants) |
84 |
| Actual target sample size (number of participants) |
|
| Recruitment status |
Recruiting |
| Publication URL |
N/A |
|